Skip navigation
The Black Hole

Making the case for increased federal support of biomedical research


 The Black Hole is extremely pleased to welcome Dr. Jonathan Thon to its team of regular bloggers.  Jonathan approached us last month to publish a series of articles on building a better support structure for young biomedical scientists in Canada which will be published here in four parts over the coming weeks.  As this is right up our alley, we were happy to oblige and look forward to getting his thoughts out to our readers.  He has also brought along some great ideas for bolstering the utility of the site that we hope to roll out in the coming months.  We hope that our readers will make him feel welcome and encourage him to keep contributing in the coming months.

Making the Case for Increased Federal Support of Biomedical Research
National health research funding bodies in North America sustain a high number of clinical advances, drug developments and cures proportional ((Exceptional returns: the economic value of America’s investment in medical research. 2000. and Murphy K., Topel, R. The economic value of medical research.. 1999.)); however, they cannot lobby for themselves and scientists must take up this challenge to make the case to governments for their support. As countries work to identify strategies to reduce their long-term deficits, it is imperative that governments protect, prioritize and strengthen federal investments in education, basic scientific research, and technological development, which are essential to creating economic opportunity and job growth. Although targeted spending reductions are a necessary component of long-term deficit reduction, a balanced budget cannot be achieved solely through cuts to domestic discretionary expenditures. Imprudent reductions to programs that contribute directly to economic growth undermine long-term debt reduction. Biomedical research has a demonstrated high level of return on investment, creates jobs, and result in innovations that lead to new technologies, new industries, and new companies. This type of productivity and record of achievement should be encouraged. Over the next few months this series of posts will highlight the importance of advocacy for increased federal support of national biomedical research institutes, and provide a framework for scientists to make this case to government.

Criticism may not be agreeable, but it is necessary. It fulfils the same function as pain in the human body. It calls attention to an unhealthy state of things. ~Winston Churchill

Jonathan Thon
Dr. Thon is the Founder and CEO of STRM.BIO. Before STRM.BIO Dr. Thon Founded Platelet BioGenesis where he served as CEO and Chief Scientific Officer. Before Platelet BioGenesis Dr. Thon was an Assistant Professor at Harvard Medical School.
Post a comment
University Affairs moderates all comments according to the following guidelines. If approved, comments generally appear within one business day. We may republish particularly insightful remarks in our print edition or elsewhere.

Your email address will not be published. Required fields are marked *

  1. tratamento para calvice / February 2, 2012 at 14:01

    Thanks very much, we are a medical consultory in Brazil and you provided a very useful information here!

  2. Making the Case… « Dr Thon / February 2, 2012 at 19:54

    […] Making the Case for Increased Federal Support of Biomedical Research Thursday, February 2nd, 2012 at 7:53 pm Blog Feed Comments […]

  3. Kraig Wyche / February 16, 2013 at 00:55

    Howdy our house just really likes your great blog many thanks and please carry on going

Click to fill out a quick survey